#ESMO26 | NIAGARA Perioperative durva+ chemo improved EFS in molecular subtypes of MIBC. TMB-high: HR 0.44 TP53-mut: HR 0.51 FGFR3-mut: HR 0.24 B-s and luminal-Inf tumors showed immune signatures and greater pCR @SCUColombia @achoHematoYOnco @myESMO @ASCO @OncoAlert @oncodaily